Amber Prosper
Family · Tomball, TXNPI 1033761291
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.
Across 178 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$594
- Amgen$279
- AbbVie$272
- Johnson & Johnson$204
- Abbott$178
- Radius Health, Inc.$163
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,060100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 39 | $594 |
| Amgen | 17 | $279 |
| AbbVie | 15 | $272 |
| Johnson & Johnson | 9 | $204 |
| Abbott | 10 | $178 |
| Radius Health, Inc. | 9 | $163 |
| AstraZeneca | 9 | $148 |
| Novo Nordisk | 9 | $128 |
| Novartis | 6 | $121 |
| Exact Sciences | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Esperion Therapeutics, Inc. | 6 | $90 |
| Pfizer | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Bayer | 2 | $55 |
| Inspire Medical Systems, Inc. | 3 | $52 |
| GSK | 3 | $51 |
| Merck | 2 | $39 |
| Boehringer Ingelheim | 2 | $37 |
| Mylan Specialty L.p. | 2 | $35 |
| Eisai Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Antares Pharma, Inc. | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Sunovion Pharmaceuticals Inc. | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
| Cequr Corporation | 1 | $13 |
How this compares
$3,060 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 38 | $48,829 |
| MounjaroTirzepatide | 16 | $24,955 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $23,965 |
| OzempicSemaglutide | 12 | $21,574 |
| XareltoRivaroxaban | 18 | $20,794 |
| TrulicityDulaglutide | 13 | $19,599 |
| JardianceEmpagliflozin | 13 | $19,544 |
| MyrbetriqMirabegron | 11 | $14,016 |
| Atorvastatin Calcium | 227 | $2,297 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,177 |
| Gabapentin | 104 | $1,773 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 61 | $1,631 |
| Levothyroxine Sodium | 202 | $1,630 |
| Tamsulosin Hcl | 79 | $1,603 |
| Rosuvastatin Calcium | 193 | $1,429 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $62 | $48,82938 claims |
| Lilly USA, LLCMounjaro, Trulicity | $594 | $44,55429 claims |
| GSKTrelegy Ellipta | $51 | $23,96522 claims |
| Novo NordiskOzempic | $128 | $21,57412 claims |
| Johnson & JohnsonXarelto | $204 | $20,79418 claims |
| Boehringer IngelheimJardiance | $37 | $19,54413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 15,456 family providers in Texas.
Other family in Tomball
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.